Below are the most recent publications written about "Aortic Diseases" by people in Profiles.
-
Fan EY, Doshi M, Simons JP, Schanzer A. Pseudoaneurysm formation at a prior aorto-aortic graft in a patient with middle aortic syndrome. J Vasc Surg. 2023 05; 77(5):1533.
-
Tanious A, Lee S, Boitano LT, DeCarlo C, Kim Y, Latz C, Colvard B, Dua A. Celiac Artery Coverage During TEVAR for Dissection and Acute Aortic Injury is Not Associated with Worse Outcomes. Ann Vasc Surg. 2023 Apr; 91:50-56.
-
Lella SK, Waller HD, Pendleton A, Latz CA, Boitano LT, Dua A. A systematic review of spinal cord ischemia prevention and management after open and endovascular aortic repair. J Vasc Surg. 2022 03; 75(3):1091-1106.
-
DeCarlo C, Latz CA, Boitano LT, Waller HD, Kim Y, Sumpio BJ, Pendleton AA, Schwartz SI, Dua A. Natural history of penetrating atherosclerotic ulcers in aortic branch vessels. J Vasc Surg. 2021 12; 74(6):1904-1909.
-
DeCarlo C, Latz CA, Boitano LT, Mohebali J, Schwartz SI, Eagleton MJ, Clouse WD, Conrad MF. An Endovascular-First Approach for Aortoiliac Occlusive Disease is Safe: Prior Endovascular Intervention is Not Associated with Inferior Outcomes after Aortofemoral Bypass. Ann Vasc Surg. 2021 Jan; 70:62-69.
-
Hirji SA, Shah R, Aranki S, McGurk S, Singh S, Mallidi HR, Pelletier M, Shekar P, Kaneko T. The impact of hospital size on national trends and outcomes in isolated open proximal aortic surgery. J Thorac Cardiovasc Surg. 2022 Apr; 163(4):1269-1278.e9.
-
Castro-Diehl C, Song RJ, Mitchell GF, McManus D, Cheng S, Vasan RS, Xanthakis V. Association of subclinical atherosclerosis with echocardiographic indices of cardiac remodeling: The Framingham Study. PLoS One. 2020; 15(5):e0233321.
-
DeCarlo C, Boitano LT, Schwartz SI, Lancaster RT, Conrad MF, Eagleton MJ, Brewster DC, Clouse WD. Operative Complexity and Prior Endovascular Intervention Negatively Impact Morbidity after Aortobifemoral Bypass in the Modern Era. Ann Vasc Surg. 2020 Jan; 62:21-29.
-
Jansen T, Kr?ller-Sch?n S, Sch?nfelder T, Foretz M, Viollet B, Daiber A, Oelze M, Brandt M, Steven S, Kvandov? M, Kalinovic S, Lagrange J, Keaney JF, M?nzel T, Wenzel P, Schulz E. a1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction. Cardiovasc Res. 2018 12 01; 114(14):1883-1893.
-
Balsam LB. True, true, or unrelated? Fluoroquinolones and aortic disease. J Thorac Cardiovasc Surg. 2019 01; 157(1):120-121.